[
    {
        "text": "[♩INTRO]",
        "start": 0.0,
        "duration": 3.439
    },
    {
        "text": "Antibodies deserve a ton of credit",
        "start": 3.52,
        "duration": 2.4
    },
    {
        "text": "they’re these sticky little Y-shaped \nproteins that our immune systems use",
        "start": 5.92,
        "duration": 3.6
    },
    {
        "text": "to spot and neutralize basically \nevery kind of threat to us.",
        "start": 9.52,
        "duration": 3.68
    },
    {
        "text": "They’re so useful that, for more than a \ncentury, scientists have been harnessing",
        "start": 13.2,
        "duration": 3.6
    },
    {
        "text": "their powers in medicines and as molecular tools.",
        "start": 16.8,
        "duration": 2.64
    },
    {
        "text": "And we’ve gotten really good at finding \na great antibody for a given job;",
        "start": 19.44,
        "duration": 4.24
    },
    {
        "text": "making it even better at binding its target, \nor antigen; and then mass-producing it.",
        "start": 23.68,
        "duration": 4.8
    },
    {
        "text": "But these monoclonal antibodies \ndo have some drawbacks.",
        "start": 28.48,
        "duration": 3.76
    },
    {
        "text": "While they’re small compared to \npathogens, they’re still big for proteins.",
        "start": 32.24,
        "duration": 4.16
    },
    {
        "text": "That makes them pretty fragile \nwhen it comes to high temperatures,",
        "start": 36.4,
        "duration": 2.96
    },
    {
        "text": "which can make shipping and storage tough.",
        "start": 39.36,
        "duration": 2.32
    },
    {
        "text": "Also, they can’t always fit into the \nnooks and crannies we want them to.",
        "start": 41.68,
        "duration": 4.08
    },
    {
        "text": "And that’s even if you can even get \nthem into the body in the first place!",
        "start": 45.76,
        "duration": 2.88
    },
    {
        "text": "Antibody drugs are typically injected, \nso they have to be mixed with liquid.",
        "start": 48.64,
        "duration": 3.76
    },
    {
        "text": "But some antibodies either don’t \ndissolve well or will clump up together",
        "start": 52.4,
        "duration": 3.44
    },
    {
        "text": "when they do, which takes injection off the table.",
        "start": 55.84,
        "duration": 2.56
    },
    {
        "text": "All of this is why, as great as \nantibodies are, cutting-edge researchers",
        "start": 58.4,
        "duration": 4.16
    },
    {
        "text": "are hoping to develop smaller \nand more stable alternatives.",
        "start": 62.56,
        "duration": 3.12
    },
    {
        "text": "And they’re willing to try just about anything",
        "start": 65.68,
        "duration": 1.68
    },
    {
        "text": "from chopping antibodies up \nto creating plastic mimics.",
        "start": 67.36,
        "duration": 3.6
    },
    {
        "text": "When you have something that’s too big,",
        "start": 70.96,
        "duration": 1.6
    },
    {
        "text": "the most obvious solution is to make it smaller.",
        "start": 72.56,
        "duration": 2.32
    },
    {
        "text": "That’s easier said than done, of course.",
        "start": 74.88,
        "duration": 2.08
    },
    {
        "text": "Luckily, with antibodies, it’s \nactually pretty straightforward.",
        "start": 76.96,
        "duration": 2.56
    },
    {
        "text": "The proteins are already kind of \nmodular, sort of like the IKEA furniture",
        "start": 79.52,
        "duration": 3.84
    },
    {
        "text": "you can piece together to \ncreate your dream bookshelf.",
        "start": 83.36,
        "duration": 2.16
    },
    {
        "text": "And in fact, the immune systems of some \nother animals take advantage of this!",
        "start": 85.52,
        "duration": 3.6
    },
    {
        "text": "Llamas and other camelids naturally \nproduce smaller antibodies that consist",
        "start": 89.12,
        "duration": 3.84
    },
    {
        "text": "of just one part of what we’d \nconsider a normal antibody.",
        "start": 92.96,
        "duration": 3.2
    },
    {
        "text": "Those helped scientists realize \nthey could somewhat pick",
        "start": 96.16,
        "duration": 2.8
    },
    {
        "text": "and choose which pieces of \nan antibody to work with.",
        "start": 98.96,
        "duration": 2.48
    },
    {
        "text": "And those choices give them control \nover things like how long the designer",
        "start": 101.44,
        "duration": 3.6
    },
    {
        "text": "antibodies stick around inside \nyou, where they’re effective,",
        "start": 105.04,
        "duration": 3.04
    },
    {
        "text": "and how they interact with their antigens.",
        "start": 108.08,
        "duration": 1.84
    },
    {
        "text": "For example, antigen-binding fragments, or Fabs,",
        "start": 109.92,
        "duration": 3.36
    },
    {
        "text": "are essentially just one \ncomplete arm of an antibody.",
        "start": 113.28,
        "duration": 2.96
    },
    {
        "text": "These fabulous mini-antibodies \nare already being used to diagnose",
        "start": 116.24,
        "duration": 4.0
    },
    {
        "text": "and treat cancer, prevent blood \nclots, and treat macular degeneration.",
        "start": 120.24,
        "duration": 3.6
    },
    {
        "text": "Or, you can use the sticky bits all by themselves",
        "start": 123.84,
        "duration": 3.28
    },
    {
        "text": "that’s essentially what \nsingle-chain variable fragments are.",
        "start": 127.12,
        "duration": 2.56
    },
    {
        "text": "They’re being used in the \ndevelopment of antitumor drugs,",
        "start": 129.68,
        "duration": 2.8
    },
    {
        "text": "as tracers for identifying and \ndiagnosing cancers, as antitoxins,",
        "start": 132.48,
        "duration": 4.24
    },
    {
        "text": "and as treatments for inflammatory \ndiseases like rheumatoid arthritis.",
        "start": 136.72,
        "duration": 3.76
    },
    {
        "text": "With both Fabs and these single-chain \nvariable fragments, the smaller size",
        "start": 140.48,
        "duration": 4.0
    },
    {
        "text": "allows them to reach locations in the \nbody that larger antibodies can’t.",
        "start": 144.48,
        "duration": 3.68
    },
    {
        "text": "But without the stabilizing \ncomponents of antibodies,",
        "start": 148.16,
        "duration": 2.88
    },
    {
        "text": "they don’t tend to hang around very long.",
        "start": 151.04,
        "duration": 1.84
    },
    {
        "text": "Plus, on a molecular scale, \nthey’re still pretty big,",
        "start": 152.88,
        "duration": 3.76
    },
    {
        "text": "and likely to be sensitive to high temperatures.",
        "start": 156.64,
        "duration": 2.08
    },
    {
        "text": "So some scientists are trying to take \nthis miniaturization idea even further.",
        "start": 158.72,
        "duration": 3.76
    },
    {
        "text": "Researchers at the University of \nWashington are hoping to design",
        "start": 162.48,
        "duration": 2.8
    },
    {
        "text": "super mini-proteins that attack and \nneutralize pathogens like antibodies do.",
        "start": 165.92,
        "duration": 4.16
    },
    {
        "text": "These tiny proteins are just as \nstable as full-sized proteins.",
        "start": 170.08,
        "duration": 3.84
    },
    {
        "text": "And they actually occur naturally \nin humans and other animals.",
        "start": 173.92,
        "duration": 2.88
    },
    {
        "text": "It’s just that, until recently, our \nmethods of detecting proteins weren’t good",
        "start": 176.8,
        "duration": 3.76
    },
    {
        "text": "at spotting ones this small.",
        "start": 180.56,
        "duration": 1.6
    },
    {
        "text": "And they are small! Between 40 and 400 \ntimes smaller than the average protein.",
        "start": 182.16,
        "duration": 4.88
    },
    {
        "text": "Rather than relying on natural ones, though,",
        "start": 187.04,
        "duration": 2.08
    },
    {
        "text": "the UW researchers are designing their own.",
        "start": 189.12,
        "duration": 2.4
    },
    {
        "text": "They’re developing machine-learning \nalgorithms which figure out the smallest",
        "start": 191.52,
        "duration": 3.6
    },
    {
        "text": "possible proteins with the highest \npossible stickiness for a given antigen.",
        "start": 195.12,
        "duration": 4.32
    },
    {
        "text": "Then, they build them and test them out.",
        "start": 199.44,
        "duration": 1.84
    },
    {
        "text": "They’ve decided to call \ntheir creations mini-binders.",
        "start": 201.28,
        "duration": 2.88
    },
    {
        "text": "Because they’re mini. And bind to things.",
        "start": 204.16,
        "duration": 2.48
    },
    {
        "text": "And since these mini-binders are \nmuch smaller than regular antibodies,",
        "start": 206.64,
        "duration": 3.68
    },
    {
        "text": "they have several advantages.",
        "start": 210.32,
        "duration": 1.28
    },
    {
        "text": "They’re much less fragile and can \nwithstand higher temperatures, for example.",
        "start": 211.6,
        "duration": 3.52
    },
    {
        "text": "Also, they could be administered \nby nose spray instead of injection.",
        "start": 215.12,
        "duration": 3.92
    },
    {
        "text": "And they can be designed to bind a \npathogen in multiple different ways",
        "start": 219.04,
        "duration": 3.6
    },
    {
        "text": "without being too unwieldy,",
        "start": 222.64,
        "duration": 1.76
    },
    {
        "text": "which would make it less likely for a \nmutation to render them ineffective.",
        "start": 224.4,
        "duration": 3.28
    },
    {
        "text": "As a proof of concept, the \nteam designed some mini-binders",
        "start": 227.68,
        "duration": 2.96
    },
    {
        "text": "to target the flu and SARS-CoV-2 viruses.",
        "start": 230.64,
        "duration": 2.96
    },
    {
        "text": "And the results were promising!",
        "start": 233.6,
        "duration": 1.68
    },
    {
        "text": "Mice who got them were just as \nlikely to survive their infections",
        "start": 235.28,
        "duration": 3.28
    },
    {
        "text": "as mice that got full-fledged antibodies.",
        "start": 238.56,
        "duration": 2.48
    },
    {
        "text": "But mini-binders are still in \nthe early stages of development,",
        "start": 241.04,
        "duration": 3.28
    },
    {
        "text": "which means we don’t yet know if \nthey would even work in humans.",
        "start": 244.32,
        "duration": 3.28
    },
    {
        "text": "So a lot needs to be done before we \ncan even consider counting on them",
        "start": 247.6,
        "duration": 3.92
    },
    {
        "text": "as a quick response to emerging pathogens.",
        "start": 251.52,
        "duration": 2.4
    },
    {
        "text": "And there are other ideas \nfor the future of antibodies…",
        "start": 253.92,
        "duration": 2.56
    },
    {
        "text": "not all of which are biological in nature.",
        "start": 256.48,
        "duration": 2.64
    },
    {
        "text": "In 2010, scientists in California \nsuccessfully made plastic antibodies.",
        "start": 259.12,
        "duration": 4.4
    },
    {
        "text": "They forced synthetic molecular subunits \nto grow into long, branching chains",
        "start": 263.52,
        "duration": 5.68
    },
    {
        "text": "around bee venom toxins.",
        "start": 269.2,
        "duration": 1.68
    },
    {
        "text": "Then, they dissolved the actual venom",
        "start": 270.88,
        "duration": 2.0
    },
    {
        "text": "leaving behind plastic polymers \nwith perfect, toxin-shaped pockets.",
        "start": 272.88,
        "duration": 4.16
    },
    {
        "text": "And they worked!",
        "start": 277.04,
        "duration": 0.96
    },
    {
        "text": "When they gave these plastic \nantibodies to mice who had been exposed",
        "start": 278.0,
        "duration": 3.12
    },
    {
        "text": "to bee venom, about 60% of them lived, \nwhile none of the control group did.",
        "start": 281.12,
        "duration": 4.96
    },
    {
        "text": "What’s great about these plastic \nversions is that they’re cheap to make",
        "start": 286.08,
        "duration": 3.12
    },
    {
        "text": "and incredibly stable.",
        "start": 289.2,
        "duration": 1.44
    },
    {
        "text": "They can just sort of hang out wherever.",
        "start": 290.64,
        "duration": 1.92
    },
    {
        "text": "That means that, in addition to working \ninside the body, they could be used",
        "start": 292.56,
        "duration": 3.36
    },
    {
        "text": "in field sensors, point-of-care \ndiagnostic tests, even deodorants!",
        "start": 295.92,
        "duration": 4.0
    },
    {
        "text": "Pretty much anywhere you might want the \nability to grab a specific molecule.",
        "start": 299.92,
        "duration": 4.0
    },
    {
        "text": "But the current process for \nmaking them does require A LOT",
        "start": 303.92,
        "duration": 3.04
    },
    {
        "text": "of the target antigen, which could be \ndifficult to obtain or might get expensive.",
        "start": 306.96,
        "duration": 4.16
    },
    {
        "text": "And the plastic antibodies made so far \naren’t as specific as actual antibodies,",
        "start": 311.12,
        "duration": 4.24
    },
    {
        "text": "nor are they smaller.",
        "start": 315.36,
        "duration": 1.52
    },
    {
        "text": "So, there’s plenty of room for improvement.",
        "start": 316.88,
        "duration": 1.44
    },
    {
        "text": "But whether we’re talking plastics \nor simply smaller proteins,",
        "start": 318.32,
        "duration": 3.12
    },
    {
        "text": "it’s clear that antibody technologies \nhave come an incredibly long way",
        "start": 321.44,
        "duration": 3.84
    },
    {
        "text": "since the horse-blood treatments \nof the 19th and 20th centuries.",
        "start": 325.28,
        "duration": 3.84
    },
    {
        "text": "They’ve helped us treat snake bites, \ncancers, inflammatory diseases,",
        "start": 329.12,
        "duration": 3.44
    },
    {
        "text": "blood clots, viruses, and blindness.",
        "start": 332.56,
        "duration": 2.32
    },
    {
        "text": "And they’ve given us a window into our bodies",
        "start": 334.88,
        "duration": 2.32
    },
    {
        "text": "from telling us what we’re sick with \nto letting us know if we’re pregnant.",
        "start": 337.2,
        "duration": 3.44
    },
    {
        "text": "Plus, they’ve become essential \ntools in the laboratory,",
        "start": 340.64,
        "duration": 2.72
    },
    {
        "text": "all thanks to their unmatched \nability to stick to specific things.",
        "start": 343.36,
        "duration": 3.6
    },
    {
        "text": "And as researchers develop new kinds of antibodies",
        "start": 346.96,
        "duration": 2.72
    },
    {
        "text": "and antibody-inspired technologies, \nthe potential applications for them,",
        "start": 349.68,
        "duration": 3.92
    },
    {
        "text": "both in and out of medicine, is \nonly going to continue to grow.",
        "start": 353.6,
        "duration": 3.6
    },
    {
        "text": "Thanks for watching this episode of SciShow",
        "start": 357.2,
        "duration": 2.08
    },
    {
        "text": "the third and final episode \nin our antibodies mini-series!",
        "start": 359.28,
        "duration": 3.04
    },
    {
        "text": "Missed parts 1 or 2? No worries!",
        "start": 362.32,
        "duration": 2.24
    },
    {
        "text": "The links are in the description.",
        "start": 364.56,
        "duration": 1.68
    },
    {
        "text": "And here’s a tip: if you click that subscribe \nbutton and ring that notification bell,",
        "start": 366.24,
        "duration": 5.12
    },
    {
        "text": "you’ll get an alert every \ntime we post a new episode.",
        "start": 371.36,
        "duration": 2.64
    },
    {
        "text": "So you’ll never miss one again!",
        "start": 374.0,
        "duration": 1.767
    },
    {
        "text": "[♩OUTRO]",
        "start": 375.825,
        "duration": 9.977
    }
]